Literature DB >> 26314313

β1-adrenoceptor Arg389Gly polymorphism and heart disease: marching toward clinical practice integration.

Katie A McCrink1, Anastasios Lymperopoulos1.   

Abstract

Entities:  

Keywords:  GWAS; cardiovascular disease; dobutamine; drug response; heart failure; hypertension; polymorphism; β-blocker; β1-adrenergic receptor

Mesh：

Substances：

Year:  2015        PMID： 26314313     DOI： 10.2217/pgs.15.104

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  3 in total

1.  Leukotriene B4 receptor 2 gene polymorphism (rs1950504, Asp196Gly) leads to enhanced cell motility under low-dose ligand stimulation.

Authors:  Jae-Hyun Jang; Jun-Dong Wei; Minsup Kim; Joo-Young Kim; Art E Cho; Jae-Hong Kim
Journal:  Exp Mol Med       Date:  2017-11-24       Impact factor: 8.718

2.  The Effect of Genetically Guided Mathematical Prediction and the Blood Pressure Response to Pharmacotherapy in Hypertension Patients.

Authors:  Eli F Kelley; Thomas P Olson; Timothy B Curry; Ryan Sprissler; Eric M Snyder
Journal:  Clin Med Insights Cardiol       Date:  2019-05-03

3.  Fuzi and Banxia Combination, Eighteen Antagonisms in Chinese Medicine, Aggravates Adriamycin-Induced Cardiomyopathy Associated with PKA/β2AR-Gs Signaling.

Authors:  Fengjiao Sun; Yingying Huang; Lili Li; Chao Yang; Pengwei Zhuang; Yanjun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-03       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.